Zynex Inc Stock Today

ZYXI Stock  USD 2.97  0.06  2.06%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Very Low

 
High
 
Low
Zynex is trading at 2.97 as of the 16th of March 2025. This is a 2.06 percent increase since the beginning of the trading day. The stock's open price was 2.91. Zynex has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
31st of December 2002
Category
Healthcare
Classification
Health Care
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. The company has 31.91 M outstanding shares of which 4.48 M shares are at this time shorted by private and institutional investors with about 57.64 trading days to cover. More on Zynex Inc

Moving together with Zynex Stock

  0.74COO Cooper Companies,PairCorr

Moving against Zynex Stock

  0.48BAX Baxter InternationalPairCorr
  0.36LUNG Pulmonx CorpPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Zynex Stock Highlights

ESG Sustainability
Environmental
Governance
Social
ChairmanThomas Sandgaard
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Distribution, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.51.5757
Notably Down
Slightly volatile
Gross Profit Margin0.550.795
Way Down
Slightly volatile
Total Current Liabilities17.7 M16.9 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total73 M69.5 M
Sufficiently Up
Slightly volatile
Total Assets128.2 M122.1 M
Sufficiently Up
Slightly volatile
Total Current Assets78.9 M75.2 M
Sufficiently Up
Slightly volatile
Debt Levels
Zynex can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zynex's financial leverage. It provides some insight into what part of Zynex's total assets is financed by creditors.
Liquidity
Zynex Inc currently holds 73.82 M in liabilities with Debt to Equity (D/E) ratio of 0.45, which is about average as compared to similar companies. Zynex Inc has a current ratio of 3.34, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Zynex's use of debt, we should always consider it together with its cash and equity.

Change In Working Capital

4.14 Million
Zynex Inc (ZYXI) is traded on NASDAQ Exchange in USA. It is located in 9655 Maroon Circle, Englewood, CO, United States, 80112 and employs 1,000 people. Zynex is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 94.78 M. Zynex Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 31.91 M outstanding shares of which 4.48 M shares are at this time shorted by private and institutional investors with about 57.64 trading days to cover. Zynex Inc currently holds about 23.53 M in cash with 12.72 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63.
Check Zynex Probability Of Bankruptcy
Ownership Allocation
Zynex Inc retains a total of 31.91 Million outstanding shares. Zynex Inc owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Zynex Ownership Details

Zynex Stock Institutional Holders

InstituionRecorded OnShares
Janney Montgomery Scott Llc2024-12-31
159.3 K
Northern Trust Corp2024-12-31
156.8 K
D. E. Shaw & Co Lp2024-12-31
141.6 K
Renaissance Technologies Corp2024-12-31
137.4 K
Congress Asset Management Company, Llp2024-12-31
121.5 K
Two Sigma Advisers, Llc2024-12-31
121 K
Marshall Wace Asset Management Ltd2024-12-31
110.4 K
Crédit Agricole S.a.2024-12-31
110.2 K
Morgan Stanley - Brokerage Accounts2024-12-31
99.5 K
Blackrock Inc2024-12-31
1.2 M
Vanguard Group Inc2024-12-31
1.1 M
View Zynex Diagnostics

Zynex Historical Income Statement

As of now, Zynex's Gross Profit is increasing as compared to previous years. The Zynex's current Other Operating Expenses is estimated to increase to about 195.7 M, while Operating Income is projected to decrease to under 3.9 M. View More Fundamentals

Zynex Stock Against Markets

Zynex Corporate Management

Already Invested in Zynex Inc?

The danger of trading Zynex Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zynex is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zynex. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zynex Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
0.09
Revenue Per Share
6.022
Quarterly Revenue Growth
(0.03)
Return On Assets
0.0289
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.